Armed antibody triggers remissions for Hodgkin's lymphoma
Thursday, November 4, 2010 - 21:30
in Health & Medicine
An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, researchers report.